Chromium–Insulin Reduces Insulin Clearance and Enhances Insulin Signaling by Suppressing Hepatic Insulin-Degrading Enzyme and Proteasome Protein Expression in KKAy Mice

JDS–chromium–insulin (CRI)-003 is a novel form of insulin that has been directly conjugated with chromium (Cr) instead of zinc. Our hypothesis was that CRI enhances insulin’s effects by altering insulin-degrading enzyme (IDE) and proteasome enzymes. To test this hypothesis, we measured hepatic IDE c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhong Q., Yu, Yongmei, Zhang, Xian H., Komorowski, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083453/
https://www.ncbi.nlm.nih.gov/pubmed/25071716
http://dx.doi.org/10.3389/fendo.2014.00099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083453/
https://www.ncbi.nlm.nih.gov/pubmed/25071716
http://dx.doi.org/10.3389/fendo.2014.00099

Ejemplares similares